Raymond James Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.28M | Buy |
|
|||||
|
2024
Q2 | $915K | Buy |
|
|||||
|
2024
Q1 | $857K | Buy |
|
|||||
|
2023
Q4 | $717K | Sell |
|
|||||
|
2023
Q3 | $662K | Sell |
|
|||||
|
2023
Q2 | $805K | Buy |
|
|||||
|
2023
Q1 | $725K | Buy |
|
|||||
|
2022
Q4 | $711K | Buy |
|
|||||
|
2022
Q3 | $519K | Buy |
|
|||||
|
2022
Q2 | $371K | Sell |
|
|||||
|
2022
Q1 | $467K | Sell |
|
|||||
|
2021
Q4 | $762K | Hold |
|
|||||
|
2021
Q3 | $856K | Buy |
|
|||||
|
2021
Q2 | $786K | Buy |
|
|||||
|
2021
Q1 | $665K | Sell |
|
|||||
|
2020
Q4 | $716K | Sell |
|
|||||
|
2020
Q3 | $739K | Buy |
|
|||||
|
2020
Q2 | $603K | Sell |
|
|||||
|
2020
Q1 | $439K | Buy |
|
|||||
|
2019
Q4 | $527K | Buy |
|
|||||
|
2019
Q3 | $407K | Buy |
|
|||||
|
2019
Q2 | $421K | Sell |
|
|||||
|
2019
Q1 | $498K | Sell |
|
|||||
|
2018
Q4 | $518K | Buy |
|
|||||
|
2018
Q3 | $616K | Buy |
|
|||||
|
2018
Q2 | $524K | Sell |
|
|||||
|
2018
Q1 | $570K | Hold |
|
|||||
|
2017
Q4 | $552K | Hold |
|
|||||
|
2017
Q3 | $563K | Hold |
|
|||||
|
2017
Q2 | $502K | Hold |
|
|||||
|
2017
Q1 | $451K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $211K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $378K | Hold |
|
|||||
|
2015
Q1 | $339K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $257K | Hold |
|
|||||
|
2013
Q3 | $255K | Hold |
|
|||||
|
2013
Q2 | $206K | Buy |
|